株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

日本脳炎ワクチンの世界市場:2019年〜2023年

Global Japanese Encephalitis Vaccines Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 881683
出版日 ページ情報 英文 131 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
日本脳炎ワクチンの世界市場:2019年〜2023年 Global Japanese Encephalitis Vaccines Market 2019-2023
出版日: 2019年06月26日 ページ情報: 英文 131 Pages
概要

日本脳炎の高リスクを予防するための国内予防接種計画は集団予防接種を含みます。この計画により、予防接種量の調達が増加します。国内予防接種計画に日本脳炎に対する予防接種を含めることは、世界の日本脳炎ワクチン市場が予測期間中に9%近くのCAGRで拡大することにつながるでしょう。

当レポートでは、世界の日本脳炎ワクチン市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年〜2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 *市場セグメンテーション:タイプ別

  • 市場セグメンテーション:タイプ別
  • 比較:タイプ別市場規模および予測(2018年〜2023年)
  • 不活化ワクチン
  • 組換えワクチン
  • 弱毒化生ワクチン
  • 市場機会:タイプ別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年〜2023年)
  • アジア
  • その他の地域
  • 欧州
  • 北米
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 新しいワクチン技術
  • BRICSから研究への強い投資
  • アジアへのインバウンド旅行の増加

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競合シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表
  • Exhibit 01: Product overview
  • Exhibit 02: Global pharmaceuticals market
  • Exhibit 03: Segments of global pharmaceuticals market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Type - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by type
  • Exhibit 20: Inactivated vaccines - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Inactivated vaccines - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Recombinant vaccines - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Recombinant vaccines - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Live attenuated vaccines - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Live attenuated vaccines - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by type
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Top 3 countries in Asia
  • Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Top 3 countries in ROW
  • Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Top 3 countries in Europe
  • Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 41: Top 3 countries in North America
  • Exhibit 42: Key leading countries
  • Exhibit 43: Market opportunity
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Vendor landscape
  • Exhibit 46: Landscape disruption
  • Exhibit 47: Vendors covered
  • Exhibit 48: Vendor classification
  • Exhibit 49: Market positioning of vendors
  • Exhibit 50: Bharat Biotech Ltd. - Vendor overview
  • Exhibit 51: Bharat Biotech Ltd. - Business segments
  • Exhibit 52: Bharat Biotech Ltd. - Organizational developments
  • Exhibit 53: Bharat Biotech Ltd. - Key offerings
  • Exhibit 54: Bharat Biotech Ltd. - Key customers
  • Exhibit 55: Biological E. Ltd. - Vendor overview
  • Exhibit 56: Biological E. Ltd. - Business segments
  • Exhibit 57: Biological E. Ltd. - Organizational developments
  • Exhibit 58: Biological E. Ltd. - Key offerings
  • Exhibit 59: Biological E. Ltd. - Key customers
  • Exhibit 60: Green Cross Corp. - Vendor overview
  • Exhibit 61: Green Cross Corp. - Business segments
  • Exhibit 62: Green Cross Corp. - Organizational developments
  • Exhibit 63: Green Cross Corp. - Geographic focus
  • Exhibit 64: Green Cross Corp. - Segment focus
  • Exhibit 65: Green Cross Corp. - Key offerings
  • Exhibit 66: Green Cross Corp. - Key customers
  • Exhibit 67: Sanofi - Vendor overview
  • Exhibit 68: Sanofi - Business segments
  • Exhibit 69: Sanofi - Organizational developments
  • Exhibit 70: Sanofi - Geographic focus
  • Exhibit 71: Sanofi - Segment focus
  • Exhibit 72: Sanofi - Key offerings
  • Exhibit 73: Sanofi - Key customers
  • Exhibit 74: Valneva SE - Vendor overview
  • Exhibit 75: Valneva SE - Business segments
  • Exhibit 76: Valneva SE - Organizational developments
  • Exhibit 77: Valneva SE - Geographic focus
  • Exhibit 78: Valneva SE - Segment focus
  • Exhibit 79: Valneva SE - Key offerings
  • Exhibit 80: Valneva SE - Key customers
  • Exhibit 81: Validation techniques employed for market sizing
  • Exhibit 82: Definition of market positioning of vendors
目次
Product Code: IRTNTR31555

About this market

Japanese encephalitis is an inflammation in the brain, which is usually asymptomatic and is caused by a mosquito-borne flavivirus. Technavio's Japanese encephalitis vaccines market analysis considers sales from different type, including inactivated vaccines, recombinant vaccines, and live attenuated vaccines. Our analysis also considers the sales of Japanese encephalitis vaccines in Asia, Europe, North America, and ROW. In 2018, the inactivated vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of choices and wide treatment options of the segment will play a significant role in the inactivated vaccines segment to maintain its market position. Also, our global Japanese encephalitis vaccines market report looks at factors such as the inclusion in national immunization plan, strategic alliances, and a growing number of awareness campaigns. However, demand-supply imbalance, geographic concentration, and weak pipeline may hamper the growth of the Japanese encephalitis vaccines industry over the forecast period.

Overview

Inclusion in national immunization plan

National immunization plans to prevent the high risk of Japanese encephalitis involves mass vaccinations. This plan results in an increased procurement of vaccination doses. The inclusion of vaccination against Japanese encephalitis in national immunization plans will lead to the expansion of the global Japanese encephalitis vaccines market at a CAGR of almost 9% during the forecast period.

Strong investments from BRICS in research

With the growing incidence of Japanese encephalitis, BRICS is developing vaccines against the indication. Pharmaceutical companies are supporting the development of these vaccines by investing in research and developmental activities. The presence of strong manufacturing facilities in BRICS countries is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global Japanese encephalitis vaccines market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global Japanese encephalitis vaccines market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Japanese encephalitis vaccines manufacturers, that include Bharat Biotech Ltd., Biological E. Ltd., Green Cross Corp., Sanofi, and Valneva SE.

Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06:* MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Inactivated vaccines - Market size and forecast 2018-2023
  • Recombinant vaccines - Market size and forecast 2018-2023
  • Live attenuated vaccines - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Novel vaccine technology
  • Strong investments from BRICS in research
  • Growing inbound travel to Asia

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Back to Top